Literature DB >> 17302765

Evaluation of platelet transfusion triggers in a tertiary-care hospital.

Bruce Cameron1, Gail Rock, Bernard Olberg, Doris Neurath.   

Abstract

BACKGROUND: Our 1100-bed referral hospital uses approximately 12,000 units of random-donor platelets (PLTs) and 1,900 units of single-donor apheresis PLTs per year with a mean of 23 percent outdating. An analysis of patterns of utilization has been undertaken to evaluate practice. STUDY DESIGN AND METHODS: Over a 9-month period, data were collected on a total of 1682 transfusion episodes in 464 patients. When the pretransfusion count was greater than 10 x 10(9) per L an attempt was made to identify the specific indications for PLT transfusions such as bleeding.
RESULTS: The majority (78%) of PLTs were transfused when the counts were above 10 x 10(9) per L. The mean pretransfusion counts for different services were: bone marrow transplant (BMT) 17.4 x 10(9) per L, hematology-oncology 14.6 x 10(9) per L, the Heart Institute 3 x 10(9) per L, and other services 36 x 10(9) per L. The percentage of transfusions given to patients with a count greater than 10 x 10(9) per L varied by service with 79 percent in BMT, 60 percent in hematology and oncology, 98 percent at the Heart Institute, and 81 percent in other services. Routine monitoring of counts shows a mean increment of 10.2 x 10(9) per L per transfusion. One hour posttransfusion counts, 24-hour posttransfustion counts, and documentation of clinical justification for transfusions was often not available.
CONCLUSIONS: The data show that most patients who receive PLTs have pretransfusion counts of more than 10 x 10(9) per L and more than one-third have pretransfusion counts of greater than 20 x 10(9) per L. The medical literature supports prophylactic PLT transfusion based solely on the count when the PLT number is 10 x 10(9) per L or less. Above this level additional justification is needed although there are different points of view concerning the appropriate triggers. Our data suggest that there is a need for clear hospital transfusion guidelines and ongoing monitoring of PLT use.

Entities:  

Mesh:

Year:  2007        PMID: 17302765     DOI: 10.1111/j.1537-2995.2007.01090.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  20 in total

1.  A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Gemma L Crighton; Erica M Wood; Simon Stanworth; Marialena Trivella; Carolyn Doree; Alan Tinmouth; Michael F Murphy
Journal:  Cochrane Database Syst Rev       Date:  2014

2.  Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Richard Gregg; Simon Stanworth; Carolyn Doree; Marialena Trivella; Michael F Murphy; Alan Tinmouth
Journal:  Cochrane Database Syst Rev       Date:  2014

3.  Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Simon Stanworth; Carolyn Doree; Marialena Trivella; Sally Hopewell; Michael F Murphy; Alan Tinmouth
Journal:  Cochrane Database Syst Rev       Date:  2014

4.  Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Simon Stanworth; Carolyn Doree; Marialena Trivella; Sally Hopewell; Michael F Murphy; Alan Tinmouth
Journal:  Cochrane Database Syst Rev       Date:  2014

Review 5.  Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia.

Authors:  Lise J Estcourt; Michael Desborough; Sally Hopewell; Carolyn Doree; Simon J Stanworth
Journal:  Cochrane Database Syst Rev       Date:  2015-12-02

Review 6.  Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders.

Authors:  Lise J Estcourt; Michael Desborough; Susan J Brunskill; Carolyn Doree; Sally Hopewell; Michael F Murphy; Simon J Stanworth
Journal:  Cochrane Database Syst Rev       Date:  2016-03-15

7.  An audit of platelet transfusion indications in acute leukaemia patients: six-year experience at an Academic Centre.

Authors:  José C Jaime-Pérez; Gerardo García-Salas; Grecia A Turrubiates-Hernández; Dalila M Alvarado-Navarro; Luis J Marfil-Rivera; David Gómez-Almaguer
Journal:  Blood Transfus       Date:  2020-11-03       Impact factor: 3.443

8.  Prophylactic platelet transfusions prior to surgery for people with a low platelet count.

Authors:  Lise J Estcourt; Reem Malouf; Carolyn Doree; Marialena Trivella; Sally Hopewell; Janet Birchall
Journal:  Cochrane Database Syst Rev       Date:  2017-09-02

9.  Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia.

Authors:  Lise J Estcourt; Michael Desborough; Sally Hopewell; Marialena Trivella; Carolyn Doree; Simon Stanworth
Journal:  Cochrane Database Syst Rev       Date:  2015-06-23

Review 10.  The effect of platelet storage temperature on haemostatic, immune, and endothelial function: potential for personalised medicine.

Authors:  Susan M Shea; Kimberly A Thomas; Philip C Spinella
Journal:  Blood Transfus       Date:  2019-07       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.